COVID-19 Vaccination Recommendations for 2024–2025 in Korea DOI Creative Commons
Wan Beom Park, Young Hoon Hwang, Ki Tae Kwon

et al.

Infection and Chemotherapy, Journal Year: 2024, Volume and Issue: 56(4), P. 453 - 453

Published: Jan. 1, 2024

The Korean Society of Infectious Diseases has been regularly publishing guidelines for adult immunization since 2007. Following the release coronavirus disease 2019 (COVID-19) vaccination recommendations in 2023, significant changes have occurred due to emergence new variant strains and waning immunity from previous vaccinations. This article provides a comprehensive update as November 2024, incorporating latest evidence guidelines. Focusing on 2024-2025 season, this reviews vaccines currently authorized Korea assesses their effectiveness against predominant JN.1 lineage variants. updated prioritize high-risk groups, including adults aged 65 older, individuals with underlying medical conditions, residents facilities vulnerable infection, pregnant women, healthcare workers, targeting strain. Additionally, COVID-19 is available all 6 months older. For most adults, single-dose strategy emphasized, while tailored schedules may be recommended immunocompromised individuals. aims optimize strategies ensure protection populations.

Language: Английский

Neutrophil Extracellular Traps (NETs) as a Potential Target for Anti-Aging: Role of Therapeutic Apheresis DOI Creative Commons
Natalia Jarzebska, Roman N. Rodionov,

Karin Voit-Bak

et al.

Hormone and Metabolic Research, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 9, 2025

Abstract Neutrophil extracellular traps (NETs) are large structures composed of chromatin, histones and granule-derived proteins released extracellularly by neutrophils. They generally considered to be a part the antimicrobial defense strategy, preventing dissemination pathogens. However, overproduction NETs or their ineffective clearance can drive various pathologies, many which associated with advanced age involve uncontrolled inflammation, oxidative, cardiovascular neurodegenerative stress as underlying mechanisms. Targeting in elderly an anti-aging therapy seems very attractive therapeutic approach. Therapeutic apheresis specific filter remove could promising strategy worth considering.

Language: Английский

Citations

1
COVID-19 Vaccination Recommendations for 2024–2025 in Korea DOI Creative Commons
Wan Beom Park, Young Hoon Hwang, Ki Tae Kwon

et al.

Infection and Chemotherapy, Journal Year: 2024, Volume and Issue: 56(4), P. 453 - 453

Published: Jan. 1, 2024

The Korean Society of Infectious Diseases has been regularly publishing guidelines for adult immunization since 2007. Following the release coronavirus disease 2019 (COVID-19) vaccination recommendations in 2023, significant changes have occurred due to emergence new variant strains and waning immunity from previous vaccinations. This article provides a comprehensive update as November 2024, incorporating latest evidence guidelines. Focusing on 2024-2025 season, this reviews vaccines currently authorized Korea assesses their effectiveness against predominant JN.1 lineage variants. updated prioritize high-risk groups, including adults aged 65 older, individuals with underlying medical conditions, residents facilities vulnerable infection, pregnant women, healthcare workers, targeting strain. Additionally, COVID-19 is available all 6 months older. For most adults, single-dose strategy emphasized, while tailored schedules may be recommended immunocompromised individuals. aims optimize strategies ensure protection populations.

Language: Английский

Citations

0